The use of INVANZ in the treatment of infections in adults was compared to that of other antibiotics: it was compared with ceftriaxone in community-acquired pneumonia (CAP; 866 patients) and urinary tract infections (592 patients), and with a combination of piperacillin and tazobactam in abdominal 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.